NIH-funded research Fellowship grant

Investigating how certain brain receptors affect brain function in Fragile X Syndrome

Official title: Examining the role of specific NMDA receptor subunits in cortical circuit dysfunction in Fragile X Syndrome

Funded at Ut Southwestern Medical Center · NIH-10926838 · Data updated 2026-11-12

This study is looking at how certain brain receptors might affect people with Fragile X Syndrome and autism, especially regarding their sensitivity to sensory experiences, and it aims to find new ways to help improve brain function through testing different treatments.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionUt Southwestern Medical Center
NIH-funded
Lab location1 site (Dallas, United States)
Project startSeptember 1, 2023
Project endAugust 31, 2026
Funding year2024
Award (this year)$39,712
NIH project number5F31HD113236-02
Project IDNIH-10926838 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals diagnosed with Fragile X Syndrome or autism who experience sensory hypersensitivity.

Less likely to help

Patients without Fragile X Syndrome or autism, or those who do not experience sensory hypersensitivity, may not benefit from this research.

What this research studies

This research explores the role of specific NMDA receptor subunits in the brain's cortical circuits, particularly in individuals with Fragile X Syndrome (FXS) and autism. By examining brain activity patterns through EEG studies and using animal models, the research aims to understand how these receptor subunits contribute to sensory hypersensitivity and circuit dysfunction. The approach involves testing various compounds that can modulate the activity of these receptors to see if they can restore normal brain function. This could lead to new insights into treatment options for those affected by FXS.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for sensory hypersensitivity and cognitive challenges in patients with Fragile X Syndrome and autism.

How similar studies have gone: Previous research has shown promising results in understanding NMDA receptor functions in related conditions, suggesting potential for success in this novel approach.

Where this research is happening

  • Ut Southwestern Medical Center
    Dallas, United States
    Active

Researchers

  • Principal investigator: Shedd, Aleya Michelle — Ut Southwestern Medical Center
  • Study coordinator: Shedd, Aleya Michelle

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.